N-Trifluoroacetyl derivatives as pharmacological agents. II. Trifluoroacetanilides: synthesis and antiinflammatory activity. 1984

M G Vigorita, and T Previtera, and G Saporito, and R Costa De Pasquale, and C Circosta, and F Occhiuto

The analogy with the anti-inflammatory trifluoromethane-sulfonanilides prompted us to the synthesis of a series of trifluoroacetanilides which were found to maintain the pharmacological properties of the analog sulfonanilides. Many of the obtained compounds inhibited either the carrageenin-induced rat paw edema and the adjuvant-induced arthritis; some showed better anti-inflammatory properties than indomethacin and phenylbutazone. Acute toxicity and ulcerogenic effects were significantly lower than those of reference drugs.

UI MeSH Term Description Entries
D008297 Male Males
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D005260 Female Females
D006633 Histamine Antagonists Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. Antihistamine,Antihistamines,Histamine Antagonist,Antagonist, Histamine,Antagonists, Histamine
D000083 Acetanilides Compounds based on N-phenylacetamide, that are similar in structure to 2-PHENYLACETAMIDES. They are precursors of many other compounds. They were formerly used as ANALGESICS and ANTIPYRETICS, but often caused lethal METHEMOGLOBINEMIA. Acetylanilines,N-Phenylacetamides
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001169 Arthritis, Experimental ARTHRITIS that is induced in experimental animals. Immunological methods and infectious agents can be used to develop experimental arthritis models. These methods include injections of stimulators of the immune response, such as an adjuvant (ADJUVANTS, IMMUNOLOGIC) or COLLAGEN. Adjuvant Arthritis,Arthritis, Adjuvant-Induced,Arthritis, Collagen-Induced,Arthritis, Adjuvant,Collagen Arthritis,Arthritides, Collagen,Arthritis, Collagen,Collagen Arthritides,Collagen-Induced Arthritides,Collagen-Induced Arthritis

Related Publications

M G Vigorita, and T Previtera, and G Saporito, and R Costa De Pasquale, and C Circosta, and F Occhiuto
September 1984, Il Farmaco; edizione scientifica,
M G Vigorita, and T Previtera, and G Saporito, and R Costa De Pasquale, and C Circosta, and F Occhiuto
May 1993, Chemical & pharmaceutical bulletin,
M G Vigorita, and T Previtera, and G Saporito, and R Costa De Pasquale, and C Circosta, and F Occhiuto
September 1992, Chemical & pharmaceutical bulletin,
M G Vigorita, and T Previtera, and G Saporito, and R Costa De Pasquale, and C Circosta, and F Occhiuto
May 2013, Bioorganic & medicinal chemistry letters,
M G Vigorita, and T Previtera, and G Saporito, and R Costa De Pasquale, and C Circosta, and F Occhiuto
January 2000, Drugs under experimental and clinical research,
M G Vigorita, and T Previtera, and G Saporito, and R Costa De Pasquale, and C Circosta, and F Occhiuto
October 1989, Chemical & pharmaceutical bulletin,
M G Vigorita, and T Previtera, and G Saporito, and R Costa De Pasquale, and C Circosta, and F Occhiuto
June 1998, Die Pharmazie,
M G Vigorita, and T Previtera, and G Saporito, and R Costa De Pasquale, and C Circosta, and F Occhiuto
April 2013, European journal of medicinal chemistry,
M G Vigorita, and T Previtera, and G Saporito, and R Costa De Pasquale, and C Circosta, and F Occhiuto
May 1969, Journal of medicinal chemistry,
M G Vigorita, and T Previtera, and G Saporito, and R Costa De Pasquale, and C Circosta, and F Occhiuto
January 2005, Acta poloniae pharmaceutica,
Copied contents to your clipboard!